BRAND_ANALYSIS #UNITEDHEALTHCARE HEALTH & PHARMA #5 OF 26 IN HEALTH & PHARMA HIGH TENSION

UnitedHealthcare

· Public · Updated 09 Jul 2026 08:27 UTC
#49 of 1208 overall by tension · #5 of 26 in Health & Pharma
32 High Tension
The Silent Giant
Analysis

Negative sentiment at -0.30 in Health & Pharma is practically a sector tradition, but UnitedHealthcare earned its score the hard way. The 7.15% stock gain is financial markets shrugging at public outrage — a dissociation between capital performance and reputational reality that cannot hold indefinitely.

IN THE NEWS (32 articles this week)
How health insurers get a free pass to deny coverage from a 52-year-old law meant to protect worker pensions - The Conversation
PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare - Yahoo Finance
UnitedHealth says most home-health diagnoses were supported in 2025 - Reuters
Cultural Score
40 / 100
Business Score
72 / 100
TENSION▂▂▂▁▁▂▂▁▃▃▃▃▃▃
CULTURAL▄▃▄▄▄▄▄▄▄▃▄▄▃▃
BUSINESS▅▅▅▅▅▆▆▄▆▆▆▆▆▆
Loading...
Wikipedia Momentum 15/40
News Presence 26/35
Search InterestRedistributed to other dimensions
Stock Momentum 24/30
Market Position 22/25
Revenue Growth 15/25
Earnings Health 11/20
Price$425.60
30d Change+7.2%
Market Cap$386.5B
Profit Margin2.7%
UnitedHealthcare's tension is 32. Commerce outpacing culture. sociologyofcapitalism.com/brand/unitedhealthcare
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/unitedhealthcare.html" width="320" height="200" frameborder="0"></iframe>